Chronic vanadyl sulfate (VOSO4) oral treatment is associated with desensitization of VOSO4-induced contractile response in isolated gastric smooth muscle cells.
Cadène
A
A
Laboratoire de Pharmacologie (UPRES 2035), Montpellier, France.
Soulié
M L
ML
Teissèdre
P L
PL
Magous
R
R
Serrano
J J
JJ
Bali
J P
JP
Cros
G
G
D000284:Administration, Oral; D000818:Animals; D004334:Drug Administration Schedule; D004353:Drug Evaluation, Preclinical; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D051381:Rats; D017208:Rats, Wistar; D013270:Stomach; D017968:Vanadium Compounds / Q000627:therapeutic use*
D007004:Hypoglycemic Agents; D017968:Vanadium Compounds; C034028:vanadyl sulfate